Gilead Sciences Inc. (GILD)

Index:

Nasdaq 100

$ 65.06
   
  • Change Today:
    $1.50
  • 52 Week High: $87.29
  • 52 Week Low: $62.71
  • Currency: US Dollars
  • Shares Issued: 1,246.00m
  • Volume: 9,793,590
  • Market Cap: $81,065m
  • RiskGrade: 120

FDA grants EUA for Eli Lilly treatment in conjunction with Remdesivir

By Alexander Bueso

Date: Friday 20 Nov 2020

LONDON (ShareCast) - (Sharecast News) - The Food and Drug Administration has granted Emergency Use Approval for baricitinib, a treatment for Covid-19 developed jointly by Eli Lilly and Incyte, in combination with Gilead Sciences's remdesivir.
EUA has been granted for use in adult and pediatric patients who require supplemental oxygen, invasive mechanical ventilation or extracorporeal membrane oxygenation.

In the case of Eli Lilly, it marked the second EUA obtained from the same drug regulator for one of its Covid-19 treatments.

On 9 November, the FDA granted EUA for Eli's neutralising antibody treatment for Covid-19 in high-risk non-hospitalised patients.

A clinical trial to determine baricitinib's efficacy and safety as a treatment for COVID-19 was ongoing.

As of 1422 GMT, shares of Eli Lilly were little changed, advancing 0.27% to $143.8, alongside a 0.69% gain for Incyte to $82.25.



Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GILD Market Data

Currency US Dollars
Share Price $ 65.06
Change Today $ 1.50
% Change 2.36 %
52 Week High $87.29
52 Week Low $62.71
Volume 9,793,590
Shares Issued 1,246.00m
Market Cap $81,065m
RiskGrade 120

What The Brokers Say

Strong Buy 4
Buy 8
Neutral 17
Sell 1
Strong Sell 0
Total 30
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 14-Jun-2024

Time Volume / Share Price
15:59 400 @ $65.07
15:59 300 @ $65.07
15:59 200 @ $65.07
15:59 300 @ $65.07
15:59 100 @ $65.07

Top of Page